BackAcumen Pharmaceuticals Overview

Acumen Pharmaceuticals Profit Margin

Latest profit margin for Acumen Pharmaceuticals: 116715.56% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Jun 2026

Annual Profit Margin (TTM)

116715.56%

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Acumen Pharmaceuticals (ABOS) FAQ

As of the most recent data (June 2026), ABOS shows a profit margin of 116715.56%. That is above the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 13.89%. Acumen Pharmaceuticals is at 116715.56%, which is higher that average. That is roughly 839998.8% above the sector mean. Use the comparison chart on this page to see how ABOS stacks up against individual peers as well.

Check the historical chart to see whether ABOS's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Acumen Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Acumen Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 116715.56%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 13.89%, while ABOS is at 116715.56%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.